Effect of dabigatran treatment at therapeutic levels on point-of-care international normalized ratio (INR).
.
Elisabeth Sellevoll
ES
Løkkebø
.
Ann Helen
AH
Kristoffersen
.
Anne
A
Stavelin
.
Una Ørvim
UØ
Sølvik
D000368:Aged; D000369:Aged, 80 and over; D000991:Antithrombins / Q000032:analysis*; D003404:Creatinine / Q000097:blood; D003430:Cross-Sectional Studies; D000069604:Dabigatran / Q000032:analysis*; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D008875:Middle Aged; D019095:Point-of-Care Systems
D000991:Antithrombins; D003404:Creatinine; D000069604:Dabigatran
Hemoclot Thrombin Inhibitor assay; activated partial thromboplastin time; dabigatran; hospital instrument; international normalized ratio (INR); oral anticoagulant; point-of-care (POC) instruments